Literature DB >> 16330175

Isolation and characterization of impurities in docetaxel.

R Vasu Dev1, J Moses Babu, K Vyas, P Sai Ram, P Ramachandra, N M Sekhar, D N Mohan Reddy, N Srinivasa Rao.   

Abstract

During the process development of docetaxel, two polar impurities (Impurities I and II) and two non-polar impurities (Impurities III and IV) were detected by high performance liquid chromatography (HPLC). All the impurities were isolated by Medium Pressure Liquid Chromatography (MPLC). The Impurities I, II, III and IV were identified as 13-[(4S,5R)-2-oxo-4-phenyl-oxazolidine-5-carboxy]-10-deacetyl baccatin III ester, 2'-epi docetaxel, 7-epi docetaxel and 13-[(4S,5R)-2-oxo-4-phenyl-oxazolidine-3,5-dicarboxyl-3-tert-butyl)]-10-deacetyl baccatin III ester, respectively, based on one- (1D) and two-dimensional (2D) nuclear magnetic resonance (NMR) spectroscopy data. The Impurity IV was crystallized and the structure was solved by single crystal X-ray diffraction (XRD). Two impurities (Impurities II and III) were found to be process related, while the remaining two impurities (Impurities I and IV) turned out to be isomers. The formation of these impurities was discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16330175     DOI: 10.1016/j.jpba.2005.10.037

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

1.  Enhancement of the solubility and efficacy of poorly water-soluble drugs by hydrophobically-modified polysaccharide derivatives.

Authors:  Widad Henni-Silhadi; Michel Deyme; Marie-Martine Boissonnade; Martine Appel; Didier Le Cerf; Luc Picton; Véronique Rosilio
Journal:  Pharm Res       Date:  2007-10-03       Impact factor: 4.200

2.  Is an alternative drug delivery system needed for docetaxel? The role of controlling epimerization in formulations and beyond.

Authors:  Arehalli S Manjappa; Peeyush N Goel; Makam P Vekataraju; Kesarla S Rajesh; Kinjal Makwana; Mukesh Ukawala; Yuvraj Nikam; Rajiv P Gude; Rayasa S Ramachandra Murthy
Journal:  Pharm Res       Date:  2013-06-12       Impact factor: 4.200

3.  Evaluation of the pharmaceutical quality of docetaxel injection using new stability indicating chromatographic methods for assay and impurities.

Authors:  Annarapu Malleswara Reddy; Nagaraju Banda; Shinde Govind Dagdu; Dama Venugopala Rao; Chandra Sekhar Kocherlakota; Vyas Krishnamurthy
Journal:  Sci Pharm       Date:  2010-03-05

4.  Design of theranostic nanomedicine (II): synthesis and physicochemical properties of a biocompatible polyphosphazene-docetaxel conjugate.

Authors:  Yong Joo Jun; Jung Hyun Park; Prakash G Avaji; Kyung Su Park; Kyung Eun Lee; Hwa Jeong Lee; Youn Soo Sohn
Journal:  Int J Nanomedicine       Date:  2017-07-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.